nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—Infusion site reaction—Paclitaxel—kidney cancer	0.0829	0.0829	CcSEcCtD
Milrinone—Torsade de pointes—Pazopanib—kidney cancer	0.0413	0.0413	CcSEcCtD
Milrinone—Arrhythmia supraventricular—Gemcitabine—kidney cancer	0.0395	0.0395	CcSEcCtD
Milrinone—Torsade de pointes—Sunitinib—kidney cancer	0.0272	0.0272	CcSEcCtD
Milrinone—Arrhythmia supraventricular—Capecitabine—kidney cancer	0.0271	0.0271	CcSEcCtD
Milrinone—Hypokalaemia—Temsirolimus—kidney cancer	0.0203	0.0203	CcSEcCtD
Milrinone—Liver function test abnormal—Pazopanib—kidney cancer	0.0194	0.0194	CcSEcCtD
Milrinone—Liver function test abnormal—Everolimus—kidney cancer	0.0153	0.0153	CcSEcCtD
Milrinone—Hypokalaemia—Everolimus—kidney cancer	0.0151	0.0151	CcSEcCtD
Milrinone—Torsade de pointes—Capecitabine—kidney cancer	0.015	0.015	CcSEcCtD
Milrinone—Hypokalaemia—Erlotinib—kidney cancer	0.0146	0.0146	CcSEcCtD
Milrinone—Ventricular extrasystoles—Paclitaxel—kidney cancer	0.0142	0.0142	CcSEcCtD
Milrinone—Bronchospasm—Everolimus—kidney cancer	0.0141	0.0141	CcSEcCtD
Milrinone—Angina pectoris—Vinblastine—kidney cancer	0.014	0.014	CcSEcCtD
Milrinone—Angina pectoris—Everolimus—kidney cancer	0.014	0.014	CcSEcCtD
Milrinone—Ventricular fibrillation—Capecitabine—kidney cancer	0.0137	0.0137	CcSEcCtD
Milrinone—Hypokalaemia—Sorafenib—kidney cancer	0.0131	0.0131	CcSEcCtD
Milrinone—Ventricular tachycardia—Paclitaxel—kidney cancer	0.0128	0.0128	CcSEcCtD
Milrinone—Liver function test abnormal—Sunitinib—kidney cancer	0.0128	0.0128	CcSEcCtD
Milrinone—Hypokalaemia—Sunitinib—kidney cancer	0.0126	0.0126	CcSEcCtD
Milrinone—Liver function test abnormal—Dactinomycin—kidney cancer	0.0121	0.0121	CcSEcCtD
Milrinone—Ventricular extrasystoles—Capecitabine—kidney cancer	0.0116	0.0116	CcSEcCtD
Milrinone—Chest pain—Temsirolimus—kidney cancer	0.0114	0.0114	CcSEcCtD
Milrinone—Anaphylactic shock—Temsirolimus—kidney cancer	0.011	0.011	CcSEcCtD
Milrinone—Chest pain—Pazopanib—kidney cancer	0.0108	0.0108	CcSEcCtD
Milrinone—Thrombocytopenia—Temsirolimus—kidney cancer	0.0107	0.0107	CcSEcCtD
Milrinone—Liver function test abnormal—Gemcitabine—kidney cancer	0.0103	0.0103	CcSEcCtD
Milrinone—Hypokalaemia—Gemcitabine—kidney cancer	0.0101	0.0101	CcSEcCtD
Milrinone—Thrombocytopenia—Pazopanib—kidney cancer	0.0101	0.0101	CcSEcCtD
Milrinone—Arrhythmia—Erlotinib—kidney cancer	0.00989	0.00989	CcSEcCtD
Milrinone—Bronchospasm—Gemcitabine—kidney cancer	0.00945	0.00945	CcSEcCtD
Milrinone—Tremor—Everolimus—kidney cancer	0.00936	0.00936	CcSEcCtD
Milrinone—Ventricular arrhythmia—Doxorubicin—kidney cancer	0.00916	0.00916	CcSEcCtD
Milrinone—Arrhythmia—Sorafenib—kidney cancer	0.00889	0.00889	CcSEcCtD
Milrinone—Liver function test abnormal—Paclitaxel—kidney cancer	0.00859	0.00859	CcSEcCtD
Milrinone—Arrhythmia—Sunitinib—kidney cancer	0.00856	0.00856	CcSEcCtD
Milrinone—Chest pain—Everolimus—kidney cancer	0.0085	0.0085	CcSEcCtD
Milrinone—Hypokalaemia—Paclitaxel—kidney cancer	0.00847	0.00847	CcSEcCtD
Milrinone—Chest pain—Erlotinib—kidney cancer	0.0082	0.0082	CcSEcCtD
Milrinone—Thrombocytopenia—Vinblastine—kidney cancer	0.00801	0.00801	CcSEcCtD
Milrinone—Thrombocytopenia—Everolimus—kidney cancer	0.00798	0.00798	CcSEcCtD
Milrinone—Thrombocytopenia—Erlotinib—kidney cancer	0.0077	0.0077	CcSEcCtD
Milrinone—Hypotension—Everolimus—kidney cancer	0.00762	0.00762	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—kidney cancer	0.00751	0.00751	CcSEcCtD
Milrinone—Chest pain—Sunitinib—kidney cancer	0.0071	0.0071	CcSEcCtD
Milrinone—Anaphylactic shock—Sorafenib—kidney cancer	0.00707	0.00707	CcSEcCtD
Milrinone—Liver function test abnormal—Capecitabine—kidney cancer	0.00705	0.00705	CcSEcCtD
Milrinone—Hypokalaemia—Capecitabine—kidney cancer	0.00695	0.00695	CcSEcCtD
Milrinone—Thrombocytopenia—Sorafenib—kidney cancer	0.00693	0.00693	CcSEcCtD
Milrinone—Rash—Temsirolimus—kidney cancer	0.00691	0.00691	CcSEcCtD
Milrinone—Dermatitis—Temsirolimus—kidney cancer	0.0069	0.0069	CcSEcCtD
Milrinone—Arrhythmia—Gemcitabine—kidney cancer	0.00687	0.00687	CcSEcCtD
Milrinone—Headache—Temsirolimus—kidney cancer	0.00686	0.00686	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—kidney cancer	0.00678	0.00678	CcSEcCtD
Milrinone—Thrombocytopenia—Sunitinib—kidney cancer	0.00666	0.00666	CcSEcCtD
Milrinone—Rash—Pazopanib—kidney cancer	0.00651	0.00651	CcSEcCtD
Milrinone—Dermatitis—Pazopanib—kidney cancer	0.0065	0.0065	CcSEcCtD
Milrinone—Bronchospasm—Capecitabine—kidney cancer	0.00649	0.00649	CcSEcCtD
Milrinone—Headache—Pazopanib—kidney cancer	0.00647	0.00647	CcSEcCtD
Milrinone—Angina pectoris—Capecitabine—kidney cancer	0.00643	0.00643	CcSEcCtD
Milrinone—Thrombocytopenia—Dactinomycin—kidney cancer	0.00631	0.00631	CcSEcCtD
Milrinone—Anaphylactic shock—Vincristine—kidney cancer	0.00576	0.00576	CcSEcCtD
Milrinone—Arrhythmia—Paclitaxel—kidney cancer	0.00575	0.00575	CcSEcCtD
Milrinone—Chest pain—Gemcitabine—kidney cancer	0.0057	0.0057	CcSEcCtD
Milrinone—Thrombocytopenia—Vincristine—kidney cancer	0.00564	0.00564	CcSEcCtD
Milrinone—Anaphylactic shock—Gemcitabine—kidney cancer	0.00546	0.00546	CcSEcCtD
Milrinone—Hypotension—Vincristine—kidney cancer	0.00538	0.00538	CcSEcCtD
Milrinone—Thrombocytopenia—Gemcitabine—kidney cancer	0.00535	0.00535	CcSEcCtD
Milrinone—Tremor—Paclitaxel—kidney cancer	0.00525	0.00525	CcSEcCtD
Milrinone—Rash—Everolimus—kidney cancer	0.00514	0.00514	CcSEcCtD
Milrinone—Dermatitis—Everolimus—kidney cancer	0.00513	0.00513	CcSEcCtD
Milrinone—Headache—Vinblastine—kidney cancer	0.00513	0.00513	CcSEcCtD
Milrinone—Headache—Everolimus—kidney cancer	0.00511	0.00511	CcSEcCtD
Milrinone—Hypotension—Gemcitabine—kidney cancer	0.0051	0.0051	CcSEcCtD
Milrinone—Rash—Erlotinib—kidney cancer	0.00496	0.00496	CcSEcCtD
Milrinone—Dermatitis—Erlotinib—kidney cancer	0.00495	0.00495	CcSEcCtD
Milrinone—Headache—Erlotinib—kidney cancer	0.00493	0.00493	CcSEcCtD
Milrinone—Chest pain—Paclitaxel—kidney cancer	0.00477	0.00477	CcSEcCtD
Milrinone—Arrhythmia—Capecitabine—kidney cancer	0.00472	0.00472	CcSEcCtD
Milrinone—Anaphylactic shock—Paclitaxel—kidney cancer	0.00457	0.00457	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—kidney cancer	0.00454	0.00454	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—kidney cancer	0.00448	0.00448	CcSEcCtD
Milrinone—Thrombocytopenia—Paclitaxel—kidney cancer	0.00448	0.00448	CcSEcCtD
Milrinone—Rash—Sorafenib—kidney cancer	0.00446	0.00446	CcSEcCtD
Milrinone—Dermatitis—Sorafenib—kidney cancer	0.00446	0.00446	CcSEcCtD
Milrinone—Headache—Sorafenib—kidney cancer	0.00443	0.00443	CcSEcCtD
Milrinone—Tremor—Capecitabine—kidney cancer	0.00431	0.00431	CcSEcCtD
Milrinone—Rash—Sunitinib—kidney cancer	0.00429	0.00429	CcSEcCtD
Milrinone—Dermatitis—Sunitinib—kidney cancer	0.00429	0.00429	CcSEcCtD
Milrinone—Hypotension—Paclitaxel—kidney cancer	0.00427	0.00427	CcSEcCtD
Milrinone—Headache—Sunitinib—kidney cancer	0.00426	0.00426	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—kidney cancer	0.00414	0.00414	CcSEcCtD
Milrinone—Rash—Dactinomycin—kidney cancer	0.00406	0.00406	CcSEcCtD
Milrinone—Chest pain—Capecitabine—kidney cancer	0.00391	0.00391	CcSEcCtD
Milrinone—Thrombocytopenia—Capecitabine—kidney cancer	0.00367	0.00367	CcSEcCtD
Milrinone—Rash—Vincristine—kidney cancer	0.00363	0.00363	CcSEcCtD
Milrinone—Dermatitis—Vincristine—kidney cancer	0.00363	0.00363	CcSEcCtD
Milrinone—Headache—Vincristine—kidney cancer	0.00361	0.00361	CcSEcCtD
Milrinone—Hypotension—Capecitabine—kidney cancer	0.00351	0.00351	CcSEcCtD
Milrinone—Rash—Gemcitabine—kidney cancer	0.00344	0.00344	CcSEcCtD
Milrinone—Dermatitis—Gemcitabine—kidney cancer	0.00344	0.00344	CcSEcCtD
Milrinone—Headache—Gemcitabine—kidney cancer	0.00342	0.00342	CcSEcCtD
Milrinone—Arrhythmia—Doxorubicin—kidney cancer	0.00304	0.00304	CcSEcCtD
Milrinone—Rash—Paclitaxel—kidney cancer	0.00288	0.00288	CcSEcCtD
Milrinone—Dermatitis—Paclitaxel—kidney cancer	0.00288	0.00288	CcSEcCtD
Milrinone—Headache—Paclitaxel—kidney cancer	0.00286	0.00286	CcSEcCtD
Milrinone—Chest pain—Doxorubicin—kidney cancer	0.00252	0.00252	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—kidney cancer	0.00242	0.00242	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—kidney cancer	0.00237	0.00237	CcSEcCtD
Milrinone—Rash—Capecitabine—kidney cancer	0.00237	0.00237	CcSEcCtD
Milrinone—Dermatitis—Capecitabine—kidney cancer	0.00236	0.00236	CcSEcCtD
Milrinone—Headache—Capecitabine—kidney cancer	0.00235	0.00235	CcSEcCtD
Milrinone—Hypotension—Doxorubicin—kidney cancer	0.00226	0.00226	CcSEcCtD
Milrinone—Rash—Doxorubicin—kidney cancer	0.00153	0.00153	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—kidney cancer	0.00152	0.00152	CcSEcCtD
Milrinone—Headache—Doxorubicin—kidney cancer	0.00152	0.00152	CcSEcCtD
